Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-11

Clinical Trial Update: Assessing Gut Microbiome Changes Before and After an Oral Nutritional Supplement Intake Using the SIMBA Capsule in Diabetic Participants [Phase 1]

View source ↗

Summary

Phase 1 study evaluating gut microbiome changes in adults with Type 2 diabetes before and after the SIMBA Capsule oral nutritional supplement; status is not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMBA Capsule (oral nutritional supplement)

Snippet

Sponsor: Nimble Science Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: NOT_YET_RECRUITING